State variations in chronic obstructive pulmonary disease (COPD) outcomes suggest that the condition is more common in large rural areas compared with metropolitan areas, according to the Morbidity and Mortality Weekly Report from CDC.
State variations in chronic obstructive pulmonary disease (COPD) outcomes suggest that the condition is more common in large rural areas compared with metropolitan areas, according to the Morbidity and Mortality Weekly Report from CDC.
The report analyzed 2015 data from the Behavioral Risk Factor Surveillance System, Medicare hospital records, and death certificate data from the National Vital Statistics System, and identified 15.5 million adults who received a COPD diagnosis with approximately 335,000 Medicare hospitalizations and 150,350 deaths in which COPD was the underlying cause.
The analysis found that COPD prevalence, Medicare hospitalizations, and deaths were “significantly higher” among people in rural areas compared with people in other areas of the country.
Age-adjusted prevalence of COPD diagnosis ranged from 4.7% among populations in large metropolitan centers to 8.2% in rural areas. The analysis also found that 7 states were in the highest quartiles for COPD prevalence, Medicare hospitalizations, and deaths: Alabama, Arkansas, Indiana, Kentucky, Mississippi, Tennessee, and West Virginia. Of those 7 states, Arkansas, Mississippi, and West Virginia were also in the highest quartile for percentage of rural residents.
The researchers speculated that rural populations had a higher risk of COPD because they have a greater proportion with a history of smoking, less access to smoking cessation programs, and higher proportions of uninsured or lower socioeconomic residents. Barriers to care in these areas include cultural perceptions about seeking care, distance to travel for care, a lack of services available, and financial burden. Limited access to services also affects access to early diagnosis, prompt treatment, and management of COPD.
“Healthcare providers and community partners who serve rural residents can help adults with COPD increase access to and participation in healthcare interventions,” the authors concluded. “Federal agencies are promoting collaborative and coordinated efforts to educate the public, providers, patients, and caregivers about COPD and improve the prevention, diagnosis, and treatment of COPD.”
References
Croft JB, Wheaton AG, Liu Y, et al. Urban-rural county and state differences in chronic obstructive pulmonary disease—United States, 2015. MMWR Morb Mortal Wkly Rep. 2018:67(7);205-211. doi: http://dx.doi.org/10.15585/mmwr.mm6707a1.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More